| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | G01AX17 |
| UNII: | TCN4MG2VXS |
| InChI Key | ILAYIAGXTHKHNT-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H19N5 |
| Molecular Weight | 329.41 |
| AlogP | 4.76 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 73.63 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 25.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Reverse transcriptase inhibitor | PubMed |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| HIV Infections | 3 | D015658 | ClinicalTrials |
| HIV Infections | 3 | D015658 | ClinicalTrials |
| Acquired Immunodeficiency Syndrome | 1 | D000163 | ClinicalTrials |
| Infections | 1 | D007239 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 244767-67-7 |
| ChEMBL | CHEMBL70663 |
| DrugBank | DB08639 |
| EPA CompTox | DTXSID40179244 |
| FDA SRS | TCN4MG2VXS |
| PDB | TPB |
| PubChem | 214347 |
| SureChEMBL | SCHEMBL383370 |
| ZINC | ZINC000000007761 |